Bulk RNA sequencing analysis of tissues from primary GBM patients revealed markedly increased (p < 0.001) BTK expression levels in tumor tissues (n = 99) compared to tumor-free cortex tissues (n = 42;Fig. 1a) consistent with prior studies [17,43]. The gene discussed is BTK; the disease is glioblastoma.